In vitro cytotoxicity and anti-cancer drug release behavior of methionine-coated magnetite nanoparticles as carriers
- PMID: 36224407
- DOI: 10.1007/s12032-022-01838-1
In vitro cytotoxicity and anti-cancer drug release behavior of methionine-coated magnetite nanoparticles as carriers
Retraction in
-
Retraction Note: In vitro cytotoxicity and anti-cancer drug release behavior of methionine-coated magnetite nanoparticles as carriers.Med Oncol. 2025 Mar 22;42(5):130. doi: 10.1007/s12032-025-02688-3. Med Oncol. 2025. PMID: 40119976 No abstract available.
Abstract
A novel and specific drug delivery for in vitro cancer targeted are developed successfully by a simple one-step method. A CoFe2O4@Methionine core-shell nanoparticle was prepared by the reflux assay which amino acid in the surface makes ferrite biocompatible, enhances its chemical stability, and improves the drug-loading capacity. The synthesized nanoparticles were characterized using FTIR, TGA, XRD, SEM, TEM, and VSM which coating amino acid on the surface of CoFe2O4 was confirmed by XRD and TGA. The appearance of a new peak for C≡N confirms the formation of Letrozole-loaded carrier in the FTIR. The vibrating sample magnetometer of both bare CoFe2O4 and Methionine-coated CoFe2O4 nanoparticles exhibited room-temperature superparamagnetic behavior with a saturation value of 46 emu/g and 16.8 emu/g, respectively. The morphology and size of samples were characterized by SEM and TEM that the average size of the particle was around 28-29 nm. The loading of Letrozole and the effect of pH (5, 7.4) on the release behavior of the carrier was studied. The result of the drug release in pH is equal to 5 was about 88% which higher than pH is equal to 7.4. Also, the preparation had been evaluated for determining its cytotoxicity using MCF-7, MDA-MB-231, and MCF10A cells as an in vitro model, and the result vitro experiments showed that CoFe2O4@Methionine could significantly reduce cancer in cells model. These results demonstrate that core-shell nanoparticle was prepared is biocompatible and have potential use as drug delivery.
Keywords: Cell line; CoFe2O4 nanoparticles; Cytotoxicity; Drug delivery; Letrozole; Methionine.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Release of a liver anticancer drug, sorafenib from its PVA/LDH- and PEG/LDH-coated iron oxide nanoparticles for drug delivery applications.Sci Rep. 2020 Dec 9;10(1):21521. doi: 10.1038/s41598-020-76504-5. Sci Rep. 2020. PMID: 33298980 Free PMC article.
-
Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug.ACS Appl Mater Interfaces. 2013 May;5(9):3884-93. doi: 10.1021/am400572b. Epub 2013 Apr 23. ACS Appl Mater Interfaces. 2013. PMID: 23551195
-
Biocompatible superparamagnetic core-shell nanoparticles for potential use in hyperthermia-enabled drug release and as an enhanced contrast agent.Nanotechnology. 2020 Sep 11;31(37):375102. doi: 10.1088/1361-6528/ab91f6. Epub 2020 May 11. Nanotechnology. 2020. PMID: 32392545
-
Synthesis of Cross-linked Poly (N-isopropylacrylamide) Magnetic Nano Composite for Application in the Controlled Release of Doxorubicin.Pharm Nanotechnol. 2017;5(1):67-75. doi: 10.2174/2211738505666170109155247. Pharm Nanotechnol. 2017. PMID: 28948911
-
Thermal and microwave synthesized SPIONs: Energy effects on the efficiency of nano drug carriers.Mater Sci Eng C Mater Biol Appl. 2020 Jun;111:110792. doi: 10.1016/j.msec.2020.110792. Epub 2020 Feb 29. Mater Sci Eng C Mater Biol Appl. 2020. PMID: 32279785
Cited by
-
Molecular and therapeutic effect of CRISPR in treating cancer.Med Oncol. 2023 Jan 17;40(2):81. doi: 10.1007/s12032-022-01930-6. Med Oncol. 2023. Retraction in: Med Oncol. 2025 Mar 24;42(5):132. doi: 10.1007/s12032-025-02692-7. PMID: 36650384 Free PMC article. Retracted. Review.
-
Application of biosensors in cancers, an overview.Front Bioeng Biotechnol. 2023 Aug 24;11:1193493. doi: 10.3389/fbioe.2023.1193493. eCollection 2023. Front Bioeng Biotechnol. 2023. Retraction in: Front Bioeng Biotechnol. 2023 Dec 05;11:1343822. doi: 10.3389/fbioe.2023.1343822. PMID: 37691902 Free PMC article. Retracted. Review.
-
Human Dignity and Artificial Intelligence in Healthcare: A Basis for a Catholic Ethics on AI.J Relig Health. 2024 Dec 27. doi: 10.1007/s10943-024-02206-1. Online ahead of print. J Relig Health. 2024. PMID: 39730882
-
Analysis of Conocurvone, Ganoderic acid A and Oleuropein molecules against the main protease molecule of COVID-19 by in silico approaches: Molecular dynamics docking studies.Eng Anal Bound Elem. 2023 May;150:583-598. doi: 10.1016/j.enganabound.2023.02.043. Epub 2023 Feb 27. Eng Anal Bound Elem. 2023. Retraction in: Eng Anal Bound Elem. 2023 Nov;156:239. doi: 10.1016/j.enganabound.2023.08.015. PMID: 36875283 Free PMC article. Retracted.
-
Newly Synthesized CoFe2-xDyxO4 (x = 0; 0.1; 0.2; 0.4) Nanoparticles Reveal Promising Anticancer Activity against Melanoma (A375) and Breast Cancer (MCF-7) Cells.Int J Mol Sci. 2023 Oct 29;24(21):15733. doi: 10.3390/ijms242115733. Int J Mol Sci. 2023. PMID: 37958717 Free PMC article.
References
-
- Anand V, Singh K, Kaur K, Bhatia G. Drug loaded silica coated MnFe2O4 ferromagnetic biomaterials for targeted cancer treatment. AIP Conference Proceedings. AIP Publishing LLC. 2017;p. 040009.
-
- Anand V, Singh K, Kaur K. Evaluation of zinc and magnesium doped 45S5 mesoporous bioactive glass system for the growth of hydroxyl apatite layer. J Non-Crys Sol. 2014;406:88–94.
-
- Lee DW, Barrett DM, Mackall C, Orentas R, Grupp SA. The future is now: chimeric antigen receptors as new targeted therapies for childhood cancer. AACR; 2012.
-
- Vallet-Regí M, Ragel CV, Salinas AJ. Glasses with medical applications. Eur J Inorg Chem. 2003;2003:1029–42.
-
- Vasir JK, Labhasetwar V. Targeted drug delivery in cancer therapy. Technol Cancer Res Treat. 2005;4:363–74. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous